drugset / Trial / NCT00366236

Study of Nitazoxanide in the Treatment of Amebiasis in Adults and Adolescents

NCT00366236

Phase 3 Completed 50 enrolled Romark Laboratories L.C.
RandomizedSingle-groupDouble-blindTreatment

Summary

The purpose of this study is to determine the effect of nitazoxanide tablets in treating diarrhea caused by Entamoeba histolytica in adults and adolescents.

Timeline

Start
2004-02
Primary completion
Completion
2005-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Nitazoxanide Other / unclassified